184 related articles for article (PubMed ID: 9239774)
1. Human intravenous immunoglobulin in primary and secondary antibody deficiencies.
Stiehm ER
Pediatr Infect Dis J; 1997 Jul; 16(7):696-707. PubMed ID: 9239774
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immune globulin in primary immunodeficiency.
Haeney M
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):11-5. PubMed ID: 8033427
[TBL] [Abstract][Full Text] [Related]
3. Post-marketing observational study on 5% intravenous immunoglobulin therapy in patients with secondary immunodeficiency and recurrent serious bacterial infections.
Günther G; Dreger B
Microbiol Immunol; 2013 Jul; 57(7):527-35. PubMed ID: 23607863
[TBL] [Abstract][Full Text] [Related]
4. Safety of high-dose intravenous immunoglobulin in systemic autoimmune diseases.
Tufan F; Kamali S; Erer B; Gul A; Inanc M; Ocal L; Konice M; Aral O
Clin Rheumatol; 2007 Nov; 26(11):1913-5. PubMed ID: 17636363
[TBL] [Abstract][Full Text] [Related]
5. [Current developments in the use of intravenous immunoglobulins].
Bardare M; Dellepiane RM
Minerva Pediatr; 1991 Nov; 43(11):665-74. PubMed ID: 1791793
[TBL] [Abstract][Full Text] [Related]
6. Clinical use of immune serum globulin as replacement therapy in patients with primary immunodeficiency syndromes.
Schwartz SA
Clin Rev Allergy; 1992; 10(1-2):1-12. PubMed ID: 1606517
[TBL] [Abstract][Full Text] [Related]
7. Safety of intravenous immunoglobulin (IVIG) therapy.
Katz U; Achiron A; Sherer Y; Shoenfeld Y
Autoimmun Rev; 2007 Mar; 6(4):257-9. PubMed ID: 17317619
[TBL] [Abstract][Full Text] [Related]
8. Immune globulin (human) 10 % liquid: a review of its use in primary immunodeficiency disorders.
McCormack PL
BioDrugs; 2013 Aug; 27(4):393-400. PubMed ID: 23703447
[TBL] [Abstract][Full Text] [Related]
9. Use of intravenous immunoglobulin G (IVIG).
Looney RJ; Huggins J
Best Pract Res Clin Haematol; 2006; 19(1):3-25. PubMed ID: 16377538
[TBL] [Abstract][Full Text] [Related]
10. Evaluating dose ratio of subcutaneous to intravenous immunoglobulin therapy among patients with primary immunodeficiency disease switching to 20% subcutaneous immunoglobulin therapy.
Krishnarajah G; Lehmann JK; Ellman B; Bhak RH; DerSarkissian M; Leader D; Bullinger AL; Sheng Duh M
Am J Manag Care; 2016 Oct; 22(15 Suppl):s475-s481. PubMed ID: 27849353
[TBL] [Abstract][Full Text] [Related]
11. Pneumococcal antibody levels in children with PID receiving immunoglobulin.
Tuerlinckx D; Florkin B; Ferster A; De Schutter I; Chantrain C; Haerynck F; Philippet P; Strengers P; Laub R
Pediatrics; 2014 Jan; 133(1):e154-62. PubMed ID: 24366995
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics.
Shapiro RS
Pediatr Allergy Immunol; 2013 Feb; 24(1):49-53. PubMed ID: 23331529
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants.
Ohlsson A; Lacy JB
Cochrane Database Syst Rev; 2004; (1):CD000361. PubMed ID: 14973955
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants.
Ohlsson A; Lacy JB
Cochrane Database Syst Rev; 2001; (2):CD000361. PubMed ID: 11405962
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulins in infectious diseases: where do we stand?
Mouthon L; Lortholary O
Clin Microbiol Infect; 2003 May; 9(5):333-8. PubMed ID: 12848745
[TBL] [Abstract][Full Text] [Related]
16. Early intravenous immunoglobulin replacement in hypogammaglobulinemic heart transplant recipients: results of a clinical trial.
Sarmiento E; Diez P; Arraya M; Jaramillo M; Calahorra L; Fernandez-Yañez J; Palomo J; Sousa I; Hortal J; Barrio J; Alonso R; Muñoz P; Navarro J; Vicario J; Fernandez-Cruz E; Carbone J
Transpl Infect Dis; 2016 Dec; 18(6):832-843. PubMed ID: 27639067
[TBL] [Abstract][Full Text] [Related]
17. [The use of intravenous immunoglobulins in the treatment of primary immunodeficiencies].
Lewandowicz-Uszyńska A; Jankowski A
Pol Merkur Lekarski; 2011 Jun; 30(180):409-12. PubMed ID: 21751549
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of patients with primary antibody deficiencies in Germany].
Borte M; Oertelt C; Högy B
Klin Padiatr; 2005; 217(5):276-80. PubMed ID: 16167275
[TBL] [Abstract][Full Text] [Related]
19. Intravenous and subcutaneous immunoglobulin G replacement therapy.
Bonilla FA
Allergy Asthma Proc; 2016 Nov; 37(6):426-431. PubMed ID: 27931296
[TBL] [Abstract][Full Text] [Related]
20. [Intravenous immunoglobulin therapy].
Mouthon L
Rev Prat; 2005 May; 55(10):1049-56. PubMed ID: 16097244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
